Welcome to LookChem.com Sign In|Join Free
  • or
Miltefosine is a phospholipid drug that is primarily used for the treatment of specific parasitic infections, such as leishmaniasis and amebiasis. It functions by disrupting the cell membrane of the parasites, which results in their death. As the first oral drug approved for the treatment of leishmaniasis, Miltefosine provides a convenient and effective alternative to traditional injectable treatments. It has also demonstrated potential in treating other conditions, including cutaneous leishmaniasis and breast cancer. However, its use is accompanied by significant side effects, such as gastrointestinal symptoms, liver toxicity, and potential teratogenicity, necessitating careful monitoring and patient education. The emergence of drug resistance further underscores the need for ongoing research into alternative treatments and combination therapies.

89367-17-9

Post Buying Request

89367-17-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89367-17-9 Usage

Uses

Used in Pharmaceutical Industry:
Miltefosine is used as an oral treatment for parasitic infections, specifically targeting leishmaniasis and amebiasis, due to its ability to disrupt the parasites' cell membranes and induce their death.
Used in the Treatment of Cutaneous Leishmaniasis:
Miltefosine is used as a therapeutic agent for cutaneous leishmaniasis, offering an effective treatment option for this skin condition caused by parasitic infection.
Used in Oncology Research:
Miltefosine is used as a potential treatment for breast cancer, as it has shown promise in research studies, although further investigation is required to fully understand its mechanisms and efficacy in this context.
Used in Combating Drug Resistance:
Miltefosine is involved in research aimed at overcoming drug resistance in parasitic infections, as the development of resistance to current treatments is a significant concern in the field of parasitology. Continued research into alternative treatments and combination therapies is essential to address this challenge.

Check Digit Verification of cas no

The CAS Registry Mumber 89367-17-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,3,6 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 89367-17:
(7*8)+(6*9)+(5*3)+(4*6)+(3*7)+(2*1)+(1*7)=179
179 % 10 = 9
So 89367-17-9 is a valid CAS Registry Number.

89367-17-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name MILTEFOSINE

1.2 Other means of identification

Product number -
Other names HPC

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89367-17-9 SDS

89367-17-9Upstream product

89367-17-9Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 89367-17-9